Nalaganje...
Effectiveness and tolerability of twice daily dosing of deferasirox in unresponsive and intolerant transfusion-dependent beta-thalassemia patients: A narrative review
Chronic iron overload in beta-thalassemia patients after continuous blood transfusions has caused notable morbidity and mortality in these patients. The once-a-day oral iron chelator, deferasirox has established efficacy and bearable safety in adults and pediatric thalassemia patients. It is now ext...
Shranjeno v:
| izdano v: | Indian J Pharmacol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Wolters Kluwer - Medknow
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8092177/ https://ncbi.nlm.nih.gov/pubmed/33666193 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijp.IJP_333_19 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|